Display options
Share it on

Eur Heart J Suppl. 2020 Nov 18;22:L82-L85. doi: 10.1093/eurheartj/suaa141. eCollection 2020 Nov.

Old unsolved problems: when and how to treat silent ischaemia.

European heart journal supplements : journal of the European Society of Cardiology

Ciro Indolfi, Alberto Polimeni, Annalisa Mongiardo, Salvatore De Rosa, Carmen Spaccarotella

Affiliations

  1. Divisione di Cardiologia, Università degli Studi "Magna Graecia", Catanzaro, Italy.

PMID: 33654471 PMCID: PMC7904061 DOI: 10.1093/eurheartj/suaa141

Abstract

Silent myocardial ischaemia (SMI) is defined as objective evidence of ischaemia without angina (or equivalent symptoms) in the presence of coronary artery disease, differing from silent coronary artery disease. Silent myocardial ischaemia represents the majority of episodes of myocardial ischaemia at Holter monitoring. During transient myocardial ischaemia, the symptoms appear after the contraction anomalies of the left ventricle and after the ECG changes. The cause of silent myocardial ischaemia is still not well established. The severity and duration of ischaemia have been theorized as important elements in the SMI mechanism. Another possible mechanism responsible for SMI is represented by changes in the perception of painful stimuli with an increased pain threshold. Finally, a neuronal dysfunction of the diabetic, in post-infarction or a cardiac neuronal 'stunning' could play a role in SMI. In the pre-stent era, the SMI was associated with a worse prognosis. In patients with diabetes mellitus, SMI seems to be more represented because autonomic dysfunction is present in this category of patients. In conclusion, SMI is more frequent than symptomatic ischaemia. However, despite the presence of countless studies on the subject, it is not clear today whether medical therapy has equalized the risk and what the real prognosis of SMI is.

Published on behalf of the European Society of Cardiology. © The Author(s) 2020.

Keywords: Silent ischaemia; Transient myocardial ischaemia

References

  1. Am Heart J. 1985 Sep;110(3):529-34 - PubMed
  2. N Engl J Med. 2015 Nov 12;373(20):1937-46 - PubMed
  3. Lancet. 1983 Oct 1;2(8353):753-8 - PubMed
  4. Arch Intern Med. 2012 Feb 27;172(4):312-9 - PubMed
  5. Circ Cardiovasc Interv. 2012 Aug 1;5(4):476-90 - PubMed
  6. J Am Coll Cardiol. 2001 Jul;38(1):72-9 - PubMed
  7. Circulation. 1990 Oct;82(4):1296-304 - PubMed
  8. Circulation. 1996 Jun 15;93(12):2089-91 - PubMed
  9. Circulation. 1996 Mar 1;93(5):905-14 - PubMed
  10. Circulation. 2008 Mar 11;117(10):1283-91 - PubMed
  11. Am J Cardiol. 1999 Nov 15;84(10):1151-7 - PubMed
  12. Am J Physiol. 1991 Sep;261(3 Pt 2):H910-7 - PubMed
  13. Am J Cardiol. 1985 Jan 1;55(1):16-24 - PubMed
  14. Circulation. 1989 Oct;80(4):983-93 - PubMed
  15. Circulation. 2018 Jan 30;137(5):480-487 - PubMed

Publication Types